Holen Sie sich die Stockscreener-App
0.6001
0.00%
0.00
Silo Pharma Inc Aktie (SILO) Neueste Nachrichten
SILO Pharma Inc (SILO) Stock: Exploring a Year of Highs, Lows, and Trading Volume - investchronicle.com
Silo Pharma Announces Completion of Dosing in Safety Study of PTSD Drug SPC-15 - The Manila Times
Silo Pharma completes dosing in FDA-requested safety study for PTSD drug By Investing.com - Investing.com South Africa
Major PTSD Drug Advances: FDA Safety Study Complete, Novel Nasal Delivery System Shows Promise - Stock Titan
Certain Options of Silo Pharma, Inc. are subject to a Lock-Up Agreement Ending on 16-JUL-2025. - MarketScreener
Certain Common Stock of Silo Pharma, Inc. are subject to a Lock-Up Agreement Ending on 16-JUL-2025. - MarketScreener
What makes Silo Pharma Inc. stock price move sharplySmart Money Trade Setups - Newser
Why Silo Pharma Inc. stock attracts strong analyst attentionLow Risk Trading Ideas - Newser
How Silo Pharma Inc. stock performs during market volatilityStrong Buy Recommendations - Newser
Silo Pharma Faces Nasdaq Non-Compliance Notice - MSN
Silo Pharma (NASDAQ:SILO) Upgraded to “Sell” at Wall Street Zen - Defense World
Silo Pharma Secures Exclusive License for CNS Peptides - TipRanks
Silo Pharma expects SPC-15 PTSD drug preclinical data within 90 days - Investing.com
Silo Pharma Advances PTSD Drug SPC-15 Toward Planned 2025 - GlobeNewswire
Silo Pharma, Inc. Plans IND Application Submission for PTSD Drug SPC-15 with Potential Phase 1 Trial in 2026 - Nasdaq
Revolutionary PTSD Treatment Breaks 25-Year Innovation Drought: Nasal Spray Shows Promise - Stock Titan
InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO), Sever Pharma Expand Existing Agreement to Include Extrusion of Novel Ketamine Implant Therapeutic - MSN
Silo Pharma (NASDAQ:SILO) Trading Down 3.2% – Time to Sell? - Defense World
Silo Pharma receives Nasdaq notice for minimum bid price non-compliance - Investing.com Australia
Silo Pharma and Hoth Therapeutics plan joint venture for obesity treatment - Investing.com India
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
SILO Pharma Secures USPTO Approval for Key Patent Enhancing SPC-15 Protection | SILO Stock News - GuruFocus
Silo Pharma receives patent allowance for PTSD treatment technology - Investing.com
Silo Pharma receives patent allowance for PTSD treatment technology By Investing.com - Investing.com Canada
Silo Pharma, Inc. Receives Notice of Allowance for Patent Strengthening SPC-15 Treatment for PTSD - Nasdaq
Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial Nears - GlobeNewswire
Breakthrough PTSD Drug Patent: Silo Pharma's Intranasal Treatment Advances Toward Clinical Trials - Stock Titan
Silo Pharma Stock Plunges 18.76% After Bitcoin Investment - AInvest
Silo Pharma approves purchase of Bitcoin as treasury reserve asset; shares up - MSN
Silo Pharma allocates $1 million to Bitcoin holdings By Investing.com - Investing.com South Africa
Is Silo Pharma moving to BIO Protocol? No - Binance
Silo Pharma's Board Approves $1 Million Bitcoin Purchase as Treasury Reserve Asset; Shares Rise - MarketScreener
Silo Pharma (SILO) Allocates $1 Million for Bitcoin Investment | - GuruFocus
Silo Pharma allocates $1 million to Bitcoin holdings - Investing.com
Silo Pharma stock surges on Bitcoin reserve move - Investing.com
Silo Pharma stock surges on Bitcoin reserve move By Investing.com - Investing.com South Africa
Silo Pharma Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset - The Manila Times
Silo Pharma, Inc. Approves $1 Million Bitcoin Purchase as Treasury Reserve Asset - Nasdaq
Biotech Makes Bold Move: Silo Pharma Commits $1M to Bitcoin as Inflation Shield - Stock Titan
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Silo Pharma's (NASDAQ:SILO) Groundbreaking Therapies Could Change The Treatment Landscape For PTSD, Fibromyalgia, MS & Alzheimer’s - simplywall.st
Silo Pharma advances PTSD treatment with new drug-device study By Investing.com - Investing.com South Africa
Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15 - GlobeNewswire
Silo Pharma stock plunges to 52-week low of $0.47 By Investing.com - Investing.com Canada
Silo Pharma teams up with Resyca for IND-supporting intranasal drug-device study of PTSD drug - Seeking Alpha
SiloPharma (SILO) Advances SPC-15 with New Drug-Device Study Agreement | SILO Stock News - GuruFocus
Silo Pharma Collaborates With Resyca for Drug-Device Study of PTSD Drug SPC-15 - marketscreener.com
Silo Pharma advances PTSD treatment with new drug-device study - Investing.com Australia
3.69%
2.49%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):